Meirong Zhou Selected Research

Meirong Zhou Research Topics

9	Neoplasms (Cancer) 05/2024 - 11/2016
6	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2017
2	Carcinogenesis 01/2023 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2017 - 11/2016
1	Triple Negative Breast Neoplasms 05/2024
1	Glioma (Gliomas) 01/2023
1	Adenocarcinoma of Lung 01/2023
1	Neuroinflammatory Diseases 01/2022
1	Inflammation (Inflammations) 01/2022
1	Nephritis 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021

2	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2016
1	SilverIBA 05/2024
1	AcidsIBA 05/2024
1	shikoninIBA 05/2024
1	ChitosanIBA 05/2024
1	N-methyladenosineIBA 10/2023
1	ErbB Receptors (EGF Receptor)IBA 10/2023
1	MethyltransferasesIBA 10/2023
1	Hormones (Hormone)IBA 10/2023
1	Pyridinolcarbamate (P23)IBA 01/2023
1	Iodothyronine Deiodinase Type IIIBA 01/2023
1	EnzymesIBA 01/2023
1	Succinic Acid (Succinate)IBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	human ERBB2 proteinIBA 12/2022
1	pertuzumabIBA 12/2022
1	Trastuzumab (Herceptin)FDA Link 12/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	InterleukinsIBA 01/2022
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022
1	CytokinesIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Cytochrome P-450 CYP2J2 (CYP2J2)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	LactonesIBA 01/2021
1	DiterpenesIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Progesterone FDA LinkGeneric 01/2020
1	Small Nucleolar RNA (snoRNA)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2017
1	p38 Mitogen-Activated Protein KinasesIBA 01/2017
1	Proto-Oncogene Proteins c-rafIBA 11/2016
1	MicroRNAs (MicroRNA)IBA 11/2016

4	Drug Therapy (Chemotherapy) 10/2023 - 01/2021
2	Neoadjuvant Therapy 12/2022 - 04/2017